By expenditures
| Name | Title | Type |
|---|---|---|
| Diane Hobbs | Chief Financial Officer | Auditee |
| Diane Hobbs | FISCAL DIRECTOR | Auditee |
| Brad Caruso | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 338948 | 2024 | 2025-01-21 | Withumsmith+brown PC | $2.71M |
| 300616 | 2023 | 2024-03-29 | Withumsmith+brown PC | $2.47M |
| 20585 | 2022 | 2023-03-30 | Withumsmith+brown PC | $2.41M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 338948 | 2024 | 2025-01-21 | 1096229 | 2024-001 | Significant Deficiency | - | L |
| 338948 | 2024 | 2025-01-21 | 1096228 | 2024-001 | Significant Deficiency | - | L |
| 338948 | 2024 | 2025-01-21 | 519787 | 2024-001 | Significant Deficiency | - | L |
| 338948 | 2024 | 2025-01-21 | 519786 | 2024-001 | Significant Deficiency | - | L |
| 300616 | 2023 | 2024-03-29 | 966143 | 2023-001 | Significant Deficiency | Yes | L |
| 300616 | 2023 | 2024-03-29 | 966142 | 2023-001 | Significant Deficiency | Yes | L |
| 300616 | 2023 | 2024-03-29 | 966141 | 2023-001 | Significant Deficiency | Yes | L |
| 300616 | 2023 | 2024-03-29 | 966140 | 2023-001 | Significant Deficiency | Yes | L |
| 300616 | 2023 | 2024-03-29 | 389701 | 2023-001 | Significant Deficiency | Yes | L |
| 300616 | 2023 | 2024-03-29 | 389700 | 2023-001 | Significant Deficiency | Yes | L |
| 300616 | 2023 | 2024-03-29 | 389699 | 2023-001 | Significant Deficiency | Yes | L |
| 300616 | 2023 | 2024-03-29 | 389698 | 2023-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 602545 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 602544 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 602543 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 602542 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 602541 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 602540 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 602539 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 602538 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 602537 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 602536 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 602535 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 26103 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 26102 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 26101 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 26100 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 26099 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 26098 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 26097 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 26096 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 26095 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 26094 | 2022-001 | Significant Deficiency | Yes | L |
| 20585 | 2022 | 2023-03-30 | 26093 | 2022-001 | Significant Deficiency | Yes | L |